p53 and treatment of bladder cancer

被引：0
|
作者：
Scott W. Lowe
Tyler Jacks
机构：
[1] Cold Spring Harbor Laboratory,Center for Cancer Research and Howard Hughes Medical Institute
[2] Massachusetts Institute of Technology,undefined
来源：
Nature | 1997年 / 385卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：124 / 125
页数：1
相关论文
共 50 条
  • [31] Comparison of P53 protein overexpression with P53 mutation in bladder cancer: Clinical and biologic aspects
    Vet, JAM
    Bringuier, PP
    Schaafsma, HE
    Witjes, JA
    Debruyne, FMJ
    Schalken, JA
    [J]. LABORATORY INVESTIGATION, 1995, 73 (06) : 837 - 843
  • [32] Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment
    Hrstka, Roman
    Coates, Philip J.
    Vojtesek, Borivoj
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (03) : 440 - 453
  • [33] Cigarette smoking and p53 mutations in lung cancer and bladder cancer
    HusgafvelPursiainen, K
    Kannio, A
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1996, 104 : 553 - 556
  • [34] p53 gene and protein status:: The role of p53 alterations in predicting outcome in patients with bladder cancer
    George, Ben
    Datar, Ram H.
    Wu, Lin
    Cai, Jie
    Patten, Nancy
    Beil, Stephen J.
    Groshen, Susan
    Stein, John
    Skinner, Donald
    Jones, Peter A.
    Cote, Richard J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5352 - 5358
  • [35] p53 mutations in cyclophosphamide-associated bladder cancer
    Khan, MA
    Travis, LB
    Lynch, CF
    Soini, Y
    Hruszkewycz, AM
    Delgado, RM
    Holowaty, EJ
    van Leeuwen, FE
    Glimelius, B
    Stovall, M
    Boice, JD
    Tarone, RE
    Bennett, WP
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (05) : 397 - 403
  • [36] Value of p53 in the clinical management of bladder cancer.
    Bernardini, S
    Chabannes, E
    Bittard, H
    [J]. PROGRES EN UROLOGIE, 2001, 11 (02): : 201 - 208
  • [37] The role of hypoxia and p53 in the regulation of angiogenesis in bladder cancer
    Reiher, FK
    Ivanovich, M
    Huang, HH
    Smith, ND
    Bouck, NP
    Campbell, SC
    [J]. JOURNAL OF UROLOGY, 2001, 165 (06): : 2075 - 2081
  • [38] P53 mutations in human urinary bladder cancer.
    Berggren, P
    Steineck, G
    Adolfsson, J
    Borgström, E
    Hansson, J
    Norming, U
    Sandstedt, B
    Wijkström, H
    Hemminki, K
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 : 71 - 71
  • [39] Inactivation of p53 and Pten promotes invasive bladder cancer
    Puzio-Kuter, Anna M.
    Castillo-Martin, Mireia
    Kinkade, Carolyn W.
    Wang, Xi
    Shen, Tian Huai
    Matos, Tulio
    Shen, Michael M.
    Cordon-Cardo, Carlos
    Abate-Shen, Cory
    [J]. GENES & DEVELOPMENT, 2009, 23 (06) : 675 - 680
  • [40] p53 Status in Locally Advanced Bladder Cancer Reply
    Stadler, Walter M.
    Groshen, Susan
    Cote, Richard J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) : 339 - 340
12345